fda-regulation-in-2019-under-the-trump-administration

FDA Regulation in 2019 Under the Trump Administration

Live Webinar

  • 60 minutes

The FDA is taking a fresh look at how to improve its gold standard for product review and consumer protection in 2019. It is therefore important that you know what to expect from the FDA in the second year of the Trump administration, and how this will likely impact your drug and medical device products. Doing so will not only prepare you in advance for the forthcoming changes, but also keep you one step ahead of the competition.

Join this session by expert speaker Norma Skolnik, will provide special insight on topics you may not find elsewhere on the market – such as the likely trends and changes to be expected from the FDA in the coming year; what new legislation will impact the pharmaceutical and consumer healthcare industry in 2019, and how the new FDA initiatives will impact the U.S. opioid crisis.

Session Highlights:

  • How FDA plans to address the Drug cost issue

  • How FDA plans to address Opioid Addiction Epidemic.

  • FDA goals for CDER/ Drugs

  • FDA goals for Biologics

  • FDA goals for Medical Devices

  • FDA goals for Food & Food Safety

Why You Should Attend:

Attendees may not know what to expect from the FDA/ of the Trump administration in 2019 and how this will likely impact their Drug, Biotech, and Medical device products. This presentation will give them insight into what to expect from the FDA in the coming year. It will also cover potential new legislation that impacts FDA regulated products.

Who Should Attend:

  • Regulatory affairs managers, directors and associates

  • Pharmaceutical product and marketing managers

  • Consumer healthcare marketing managers

  • Lawyers in the pharmaceutical and consumer healthcare industries


 *You may ask your Question directly to our expert during the Q&A session.

** You can buy On-Demand and view it as per your convenience.

Norma Skolnik

Norma Skolnik

Norma Skolnik is currently a Regulatory Consultant with over 35 years of regulatory experience working with the pharmaceutical and dietary supplement industries. She was Director of Regulatory Affairs for the Americas for Cadbury Adams and Director of Regulatory Affairs for the Adams division of Pfizer before that. Prior to that she was Associate Director of Regulatory Affairs for the Warner-Lambert company and Associate Director Regulatory Affairs at American Home Products Whitehall-Robbins Division.

No Reviews Found

Want to attend in a Group? Call 844-810-1151 and Save upto 50%

Share this course with a friend
           

We Also Recommend

Food Safety and Pharmaceuticals

How to Prepare a Standard Operating Procedure (SOP)

Pre Recorded
AFSANEH MOTAMED KHORASANI
(Speaker)
Duration:
60 minutes

Food Safety and Pharmaceuticals

USDA Final Genetically Modified Organism (GMO) Label Rule

JOHN RYAN
(Speaker)
Date:
Apr 15, 2019 - Apr 19, 2019
Start Time:
08:00 AM (ET) | 05:00 AM (PT)
Duration:
60 minutes

Newsletter

Get Notified about News, Webinars, Community & More